Companies / Veracyte Inc / Activity
Activity — Veracyte Inc
65 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Stapley Marc CEO | Sell | Common Stock | $6.92M | -138K -23.86% | 440,494 0.55% of shares | medium |
| Jun 4, 2026 | Stapley Marc CEO | Exercise | Common Stock | $5.05M | +138K +31.34% | 578,545 0.72% of shares | low |
| Feb 26, 2026 | Stapley Marc CEO | Other | Common Stock | $1.39M | -36K -7.82% | 422,532 0.53% of shares | low |
| May 22, 2026 | Wygant Jonathan Executive | Sell | Common Stock | $1.09M | -24K -34.57% | 45,434 0.06% of shares | medium |
| Mar 4, 2026 | Stapley Marc CEO | Sell | Common Stock | $953.4K | -26K -6.85% | 357,554 0.44% of shares | medium |
| Feb 26, 2026 | Febbo Phillip G. Executive | Other | Common Stock | $948.8K | -24K -15.18% | 136,806 0.17% of shares | low |
| Mar 2, 2026 | Stapley Marc CEO | Other | Common Stock | $700.6K | -19K -4.60% | 403,077 0.50% of shares | low |
| Jun 4, 2026 | Leite John Executive | Sell | Common Stock | $699.7K | -14K -9.55% | 132,305 0.16% of shares | medium |
| Mar 4, 2026 | Stapley Marc CEO | Sell | Common Stock | $684.2K | -19K -4.77% | 383,833 0.48% of shares | medium |
| May 22, 2026 | Wygant Jonathan Executive | Exercise | Common Stock | $595.2K | +24K +52.82% | 69,434 0.09% of shares | low |
| Mar 4, 2026 | Chambers Rebecca Executive | Sell | Common Stock | $506.5K | -14K -9.61% | 131,196 0.16% of shares | medium |
| Mar 2, 2026 | Febbo Phillip G. Executive | Sell | Common Stock | $485.4K | -13K -10.27% | 117,346 0.15% of shares | medium |
| Feb 26, 2026 | Chambers Rebecca Executive | Other | Common Stock | $466.9K | -12K -7.14% | 156,771 0.20% of shares | low |
| May 20, 2026 | Epstein Robert S Director | Sell | Common Stock | $440.1K | -10K -16.01% | 52,446 0.07% of shares | medium |
| Jun 2, 2026 | Stapley Marc CEO | Other | Common Stock | $430.8K | -9K -2.00% | 440,494 0.55% of shares | low |
| Feb 26, 2026 | McGuire Annie Executive | Other | Common Stock | $421.1K | -11K -9.12% | 108,266 0.13% of shares | low |
| Feb 26, 2026 | Leite John Executive | Other | Common Stock | $345.1K | -9K -6.89% | 120,357 0.15% of shares | low |
| Mar 2, 2026 | Leite John Executive | Other | Common Stock | $270.7K | -8K -6.25% | 112,840 0.14% of shares | low |
| Mar 2, 2026 | Chambers Rebecca Executive | Other | Common Stock | $260.5K | -7K -4.61% | 149,537 0.19% of shares | low |
| Mar 2, 2026 | McGuire Annie Executive | Other | Common Stock | $248.5K | -7K -6.38% | 101,364 0.13% of shares | low |
| Mar 2, 2026 | Febbo Phillip G. Executive | Other | Common Stock | $217.3K | -6K -4.41% | 130,771 0.16% of shares | low |
| May 6, 2026 | McGuire Annie Executive | Sell | Common Stock | $204.1K | -5K -3.43% | 143,708 0.18% of shares | medium |
| May 6, 2026 | McGuire Annie Executive | Sell | Common Stock | $194.1K | -5K -3.31% | 148,810 0.19% of shares | medium |
| Jun 2, 2026 | Leite John Executive | Other | Common Stock | $194.0K | -4K -2.70% | 146,280 0.18% of shares | low |
| Mar 4, 2026 | Leite John Executive | Sell | Common Stock | $185.1K | -5K -4.66% | 107,580 0.13% of shares | medium |
| Jun 2, 2026 | Febbo Phillip G. Executive | Other | Common Stock | $178.3K | -4K -2.43% | 149,797 0.19% of shares | low |
| Jun 2, 2026 | Chambers Rebecca Executive | Other | Common Stock | $176.5K | -4K -2.05% | 176,841 0.22% of shares | low |
| Mar 4, 2026 | McGuire Annie Executive | Sell | Common Stock | $176.3K | -5K -4.93% | 96,370 0.12% of shares | medium |
| Jun 18, 2026 | Eastham Karin Director | Sell | Common Stock | $168.9K | -3K -17.00% | 15,626 0.02% of shares | medium |
| Jun 2, 2026 | McGuire Annie Executive | Other | Common Stock | $157.4K | -3K -2.29% | 140,416 0.17% of shares | low |
| Mar 4, 2026 | Chambers Rebecca Executive | Sell | Common Stock | $156.4K | -4K -2.94% | 145,137 0.18% of shares | medium |
| Mar 2, 2026 | Wygant Jonathan Executive | Other | Common Stock | $108.2K | -3K -7.93% | 34,909 0.04% of shares | low |
| Jun 4, 2026 | Chambers Rebecca Executive | Sell | Common Stock | $98.2K | -2K -1.12% | 173,280 0.22% of shares | low |
| Jun 4, 2026 | McGuire Annie Executive | Sell | Common Stock | $89.0K | -2K -1.28% | 137,240 0.17% of shares | low |
| Jun 4, 2026 | Chambers Rebecca Executive | Sell | Common Stock | $78.9K | -2K -0.90% | 175,241 0.22% of shares | low |
| Jun 4, 2026 | McGuire Annie Executive | Sell | Common Stock | $69.0K | -1K -1.00% | 139,016 0.17% of shares | low |
| Jun 2, 2026 | Wygant Jonathan Executive | Other | Common Stock | $65.1K | -1K -3.00% | 44,073 0.05% of shares | low |
| Mar 4, 2026 | McGuire Annie Executive | Sell | Common Stock | $60.5K | -2K -1.73% | 94,706 0.12% of shares | low |
| Jun 18, 2026 | Eastham Karin Director | Sell | Common Stock | $28.3K | -529 -3.39% | 15,097 0.02% of shares | low |
| Jun 11, 2026 | Miller Thomas F. Director | Grant | Common Stock | $0 | +5K +20.41% | 31,100 0.04% of shares | low |
| Jun 11, 2026 | Barr Eliav Director | Grant | Common Stock | $0 | +5K +10.30% | 56,461 0.07% of shares | low |
| Jun 11, 2026 | Bhanji Muna Director | Grant | Common Stock | $0 | +5K +13.41% | 44,582 0.06% of shares | low |
| Jun 11, 2026 | Holstein Jens Director | Grant | Common Stock | $0 | +5K +19.38% | 32,471 0.04% of shares | low |
| Jun 11, 2026 | Shafer David Brent Director | Grant | Common Stock | $0 | +5K +20.41% | 31,100 0.04% of shares | low |
| Apr 10, 2026 | Haas Kevin Richard Executive | Grant | Common Stock | $0 | +44K | 44,221 0.06% of shares | low |
| Jun 11, 2026 | Epstein Robert S Director | Grant | Common Stock | $0 | +5K +10.05% | 57,718 0.07% of shares | low |
| Jun 11, 2026 | Eastham Karin Director | Grant | Common Stock | $0 | +5K +38.90% | 18,826 0.02% of shares | low |
| Jun 11, 2026 | Jones Evan/ Fa Director | Grant | Common Stock | $0 | +5K +17.96% | 34,634 0.04% of shares | low |
| Mar 6, 2026 | Chambers Rebecca Executive | Grant | Common Stock | $0 | +13K +7.86% | 180,534 0.22% of shares | low |
| Mar 6, 2026 | Chambers Rebecca Executive | Grant | Common Stock | $0 | +36K +27.58% | 167,377 0.21% of shares | low |